NEW YORK – The methylation profiles of circulating tumor DNA may help diagnose colorectal cancer as well as predict patient prognosis, findings that may form the basis of a new cancer test.
Early detection of colorectal cancer helps improve patients' survival, but colonoscopy-based screening is invasive, time-consuming, and expensive, all of which may adversely influence patient compliance.
Also in Industry News
A comprehensive analysis of evidence-based information to help manage myopia - News-Medical.Net
Applying AI to map how COVID-19 virus attacks the heart
Abnormal calcium levels in mitochondria may cause neuronal cell death in Alzheimer's disease